VC
SANA icon

VarCov Co’s Sana Biotechnology SANA Stock Holding History

VarCov Co’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Buy
+79,895
New +$257K 0.11% 284
2026
Q1 		– Sell
-64,907
Closed -$264K – 600
2025
Q4 		$264K Buy
+64,907
New +$291K 0.1% 320

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

VarCov Co's SANA Position: Q2 2026 in Review

VarCov Co opened a new position in Sana Biotechnology (SANA) in Q2 2026: 79,895 shares worth $279K. The stake represents 0.11% of the portfolio and ranks #284 among its holdings. This is a return to the name: VarCov Co previously reported a position in SANA as recently as Q4 2025.

VarCov Co first reported a position in SANA in Q4 2025 and has held it in 2 quarters since. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • VarCov Co held 79,895 shares of Sana Biotechnology worth $279K as of Q2 2026.
  • Sana Biotechnology was a new VarCov Co position in Q2 2026.
  • Sana Biotechnology made up 0.11% of VarCov Co's portfolio in Q2 2026, its #284 holding.
  • VarCov Co first reported a position in Sana Biotechnology in Q4 2025 and has held it in 2 quarters since.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on VarCov Co's 13F filing for Q2 2026, filed 14 Aug 2026.